Home » Company Profile » Biopharma PEG Scientific Inc.

Biopharma PEG Scientific Inc.

Articles

In Vivo CAR-T and Targeted mRNA Delivery: From Research to Early Clinical Translation

Biopharma PEG Expands Advanced PEGylated Protein Development Services for Enhanced Biologic Therapies

Monodispersed Azide-PEGs: Precision Linkers Driving the Next Generation of ADC Development

Biopharma PEG Receives FDA DMF Listings for Two Key PEG Derivatives

Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

Cholesterol Used As Excipients for Lipid Nanoparticles

Tech & Analysis

Sacituzumab Govitecan Approval for Advanced Urothelial Cancer

Tech & Analysis

The Application of Click Chemistry In Life Sciences

Tech & Analysis

Study Found Cancer As The Leading Cause of Death Among Diabetics

Tech & Analysis

Sacituzumab Govitecan, An ADC Drug Against Breast Cancer

Tech & Analysis

New Nanoparticle Can Kill Cancer Cells Efficiently And Selectively

Tech & Analysis

Immunotherapy, The Most Prominent Topic In Skin Cancer Research

Tech & Analysis

Two New Diabetes Drugs Benefit For The Heart And Kidneys

Tech & Analysis

ADCs Effectively Targets Surface Protein Of Neuroblastoma In Children

Tech & Analysis

Peptide Modifications For PEGylation

Tech & Analysis

Application of PEG In Click Chemistry

Tech & Analysis

What are PEG Linkers?

Tech & Analysis

Biochempeg developed a series of PEG compounds used for Semaglutide